![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pip... DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1. Show more
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic disease, today announced the closing of its...
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced that it has entered...
Preeclampsia Program to be Initiated with a Phase 2 Investigator-sponsored Trial Beginning in Q4 2024 Key Proof-of-Concept Results Expected in the First Half of 2025 Management will Host a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.19 | -5.52325581395 | 3.44 | 3.73 | 3.24 | 41117 | 3.45602246 | CS |
4 | 1.11 | 51.8691588785 | 2.14 | 3.73 | 2.14 | 129574 | 3.01830006 | CS |
12 | 0.67 | 25.9689922481 | 2.58 | 3.73 | 2.14 | 63712 | 3.01114515 | CS |
26 | 0.45 | 16.0714285714 | 2.8 | 3.73 | 2.14 | 49975 | 2.93678349 | CS |
52 | -0.34 | -9.47075208914 | 3.59 | 3.73 | 1.9382 | 57495 | 2.85525821 | CS |
156 | -0.74 | -18.5463659148 | 3.99 | 4.82 | 1.12 | 91457 | 2.92268491 | CS |
260 | -0.52 | -13.7931034483 | 3.77 | 10.88 | 1.12 | 98727 | 4.33766568 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions